The global Dravet Syndrome Market is poised to exhibit steady revenue growth, primarily driven by the increasing prevalence of epilepsy. According to the National Organization for Rare Disorders, approximately 0.0064% of Americans, or 1 in 15,700 individuals, are believed to be affected by Dravet syndrome. Of those, around 80-90% have both a SCN1A mutation and a clinical diagnosis of DS, accounting for approximately 0.17% of all epilepsies.
https://www.reportsanddata.com..../report-detail/drave
Like
Comment
Share
